SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > UTI Mutual Fund > UTI Pharma & Healthcare Fund (D)

UTI Pharma & Healthcare Fund (D)

PLAN: Regular OPTIONS: Dividend
72.926 0.28 (0.39%)

NAV as on 03 Jul, 2015

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : UTI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Mar 2015) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Close UTI Pharma & Healthcare Fund - Income Option Newly introduced w.e.f August 01, 2005.
Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 03 Jul, 2015)

Period Returns (%) Rank #
1 mth 4.2 4
3 mth -10.9 6
6 mth 11.8 4
1 year 37.0 4
2 year 34.9 6
3 year 31.3 3
5 year 20.4 2

# Moneycontrol Rank within 6 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2015 17.8 -7.5 - - -
2014 0.9 12.6 24.0 2.4 -
2013 -4.1 10.0 5.5 8.3 23.0
2012 6.9 2.3 8.0 4.9 25.1
2011 -7.8 6.1 -7.2 -0.7 -10.0
2010 11.7 8.9 1.4 4.1 30.1

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 4.2 -10.9 11.8 37.0 34.9 31.3 20.4
Category avg 4.8 -8.3 11.9 41.1 39.5 34.8 22.7
Difference of Fund returns and Category returns -0.6 -2.6 -0.1 -4.1 -4.6 -3.5 -2.3
Best of category 6.5 -6.5 19.3 53.4 47.7 41.3 27.4
Worst of category 3.7 -10.9 5.4 34.8 34.9 31.3 20.3
Benchmark returns # 4.4 -11.2 12.3 40.2 33.1 32.8 23.5
Difference of Fund returns and Benchmark returns -0.2 0.3 -0.5 -3.2 1.8 -1.5 -3.1
# Benchmark Index: CNX Pharma

Investment Info

Investment Objective

Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.

Scheme details

Fund Type Open-Ended
Investment Plan Dividend
Launch date Jun 26, 1999
Benchmark CNX Pharma
Asset Size (Rs cr) 219.56 (Mar-31-2015)
Minimum Investment Rs.5000
Last Dividend Rs.1.70 (Oct-28-2010) View Dividend History
Bonus N.A.
Fund Manager Lalit Nambiar
View performance of schemes managed by the Fund Manager
Notes UTI Pharma & Healthcare Fund - Income Option Newly introduced w.e.f August 01, 2005.

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if redeemed within 1 Year from the date of allotment.

Contact Details

Regd. Office UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051
Tel. No. 66786666
Fax No. 26524921
Email uti@giasbm01.vsnl.net.in
Website http://www.utimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
1,127.35 -7.3 5.4 34.8 31.8 20.3
Reliance Pharma Fund - Direct (G) Not Ranked
72.64 -7.1 5.7 35.7 -- --
SBI Pharma Fund (G) Not Ranked
351.65 -6.8 18.5 51.6 41.3 27.4
SBI Pharma Fund - Direct (G) Not Ranked
49.92 -6.5 19.3 53.4 -- --
UTI Pharma & Health (G) Not Ranked
219.56 -10.9 11.8 37.0 31.3 20.4
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (May 29, 15)

Equity Sector Value
(Rs cr)
Asset %
Sun Pharma Pharmaceuticals 56.72 21.58
Dr Reddys Labs Pharmaceuticals 34.08 12.97
Lupin Pharmaceuticals 33.42 12.72
Cipla Pharmaceuticals 25.04 9.53
Divis Labs Pharmaceuticals 14.81 5.63
Aurobindo Pharm Pharmaceuticals 8.55 3.25
Cadila Health Pharmaceuticals 8.21 3.13
Sun Pharma Adv Pharmaceuticals 7.92 3.02
Strides Arcolab Pharmaceuticals 6.76 2.57
Glenmark Pharmaceuticals 6.44 2.45

Full Portfolio

Sector Allocation (May 29, 15)

Sector %

1-Year

HighLow

Pharmaceuticals 92.38 97.16 90.66

View All Sectors

Asset Allocation (%)(May 29, 15)

Equity 92.38
Others 0.00
Debt 0.05
Mutual Funds N.A
Money Market 0.00
Cash / Call 7.57

View All

Concentration

Holdings (%)
Top 5 62.43
Top 10 76.85
Sector (%)
Top 3 92.38

News & Videos

News

Messages & Community

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.